Peter Siostrzonek

3 ta ish

Ordensklinikum Linz Barmherzige Schwestern

1. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

   François Mach, Colin Baigent, Alberico L. Catapano +96

   Sharh maqolaOAOchiq kirish20194 iqtibos

   ABIABI:AkademIndex/2026.other.057765

2. EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

   Kausik K. Ray, Bart Molemans, W. Marieke Schoonen +28

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.661379

3. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage

   Bernhard Metzler, Peter Siostrzonek, Ronald K. Binder +2

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.207951